The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia (original) (raw)
Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis
B. Chong
Journal of Thrombosis and Haemostasis, 2011
View PDFchevron_right
Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia
GUALTIERO PALARETI
Thrombosis and haemostasis, 2010
View PDFchevron_right
Contributions of biological tests and the 4 Ts score in the diagnosis of heparin induced thrombocytopenia
BRAHIM ADMOU
2012
View PDFchevron_right
Over-testing for heparin induced thrombocytopenia in hospitalized patients
Shruti Chaturvedi
Journal of thrombosis and thrombolysis, 2014
View PDFchevron_right
Timely diagnosis and management of heparin‐induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T’s score and particle gel immunoassay
Steven Austin
British Journal of Haematology, 2008
View PDFchevron_right
Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia
Vishal Jindal
Journal of Blood Medicine, 2020
View PDFchevron_right
Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay
Jean AMIRAL
Transfusion, 1994
View PDFchevron_right
False-Negative Platelet Factor 4 Antibodies and Serotonin Release Assay and the Utility of Repeat Testing in the Diagnosis of Heparin-Induced Thrombocytopenia and Thrombosis
Pravin George
Case Reports in Hematology, 2019
View PDFchevron_right
PIFA PLUSS P4 Assay for Screening of Heparin-Induced Thrombocytopenia
nt nghia
Laboratory medicine, 2018
View PDFchevron_right
Thrombosis in Suspected Heparin-Induced Thrombocytopenia Occurs More Often With High Antibody Levels
John Fanikos
American Journal of Medicine
View PDFchevron_right
A prospective, blinded study of a PF4-dependent assay for HIT diagnosis
Bethany Samuelson Bannow
Blood, 2021
View PDFchevron_right
Decision Analysis for Use of Platelet Aggregation Test, Carbon 14–Serotonin Release Assay, and Heparin–Platelet Factor 4 Enzyme-Linked Immunosorbent Assay for Diagnosis of Heparin-lnduced Thrombocytopenia
J. Amiral
American Journal of Clinical Pathology, 1999
View PDFchevron_right
Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia
Jean AMIRAL
American journal of clinical pathology, 1999
View PDFchevron_right
Evaluating Heparin-Induced Thrombocytopenia: The Old and the New
M. Morel-Kopp
Seminars in Thrombosis and Hemostasis, 2012
View PDFchevron_right
Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT)
Sentot Santoso
Thrombosis Research, 2011
View PDFchevron_right
Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor …
J. Amiral
…, 1994
View PDFchevron_right
Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia in medical patients
Mahmut Yüksel
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2009
View PDFchevron_right
Adverse outcomes associated with managing suspected heparin induced thrombocytopenia in the critically ill
Ibrahim Al Nabhani
Thrombosis Research, 2020
View PDFchevron_right
Thrombosis and ELISA optical density values in hospitalized patients with heparin‐induced thrombocytopenia
Weei-yuarn Huang
Journal of Thrombosis and …, 2004
View PDFchevron_right
Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
angela rogolino
Journal of Clinical Medicine, 2020
View PDFchevron_right
Use of a whole‐cell ELISA to detect additional antibodies in setting of suspected heparin‐induced thrombocytopenia
Robert W. Maitta
European Journal of Haematology, 2019
View PDFchevron_right
Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia
Marco Vitale
Cytometry, 2001
View PDFchevron_right
Laboratory Diagnosis of Heparin-Induced Thrombocytopenia in Asian Indians as Investigated With Functional and Immunologic Methods
Rafeeq Ahmed
Clinical and Applied Thrombosis-hemostasis, 2004
View PDFchevron_right
Prevalence, isotype, and functionality of antiheparin–platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia
Sarfraz Ahmad
Thrombosis Research, 2002
View PDFchevron_right
Pathogenic heparin‐induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry
Varda Deutsch
European Journal of Haematology, 2019
View PDFchevron_right
Clinical presentation and laboratory diagnosis of heparin-induced thrombocytopenia
Eleanor Pollak
Seminars in thoracic and cardiovascular surgery, 2005
View PDFchevron_right
The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia
Clifford Takemoto
Clinical and Applied Thrombosis/Hemostasis
View PDFchevron_right
Clinical presentation and evaluation of the utility of the 4t scoring system in the diagnosis of heparin induced thrombocytopenia among patients at sultan qaboos university hospital
Khalil Al-Farsi
Hematology & Transfusion International Journal, 2018
View PDFchevron_right
Improved laboratory confirmation of heparin-induced thrombocytopenia type II. Time course of antibodies and combination of antigen and biologic assays
Job Harenberg
American journal of clinical pathology, 2001
View PDFchevron_right
Heparin‐Induced Thrombocytopenia: Pathophysiology, Diagnosis, and Treatment Monitoring
Dimitrios Stylos
Drug Development Research, 2013
View PDFchevron_right
Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytope- nia in medical patients Medikal hastalarda anti-heparin trombosit faktör 4 antikor ve heparine bağli trombositopeni sikliği
Mahmut Yüksel
2009
View PDFchevron_right
Heparin-Induced Thrombocytopenia (HIT)
Tomislav Vuk
Anticoagulant Drugs, 2018
View PDFchevron_right
The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?
Camilla Drexler
The Journal of Thoracic and Cardiovascular Surgery, 2009
View PDFchevron_right
Influence of Sample Collection and Storage on the Detection of Platelet Factor 4–Heparin Antibodies
Ian Welsby
American Journal of Clinical Pathology, 2007
View PDFchevron_right